Two parallel frontiers in computational protein design: new enzyme chemistry vs marginal ML antibody gains
chaitjo · x · 2026-10-28
A viral observation notes computational protein design now has two nearly separate frontiers: an entirely new class of chemistry available for computational enzyme design, versus ML-designed VHH antibodies binding only 5% better — highlighting the gap between method-level breakthroughs and real application gains.
More from Research
- Paper: "bottleneck pressure" metric shows where AI-infeasible work gains value as AI speeds up the rest — soumitrashukla9 · 2026-10-28
- New IEEE IT paper: geometric Jensen-Shannon divergence between Gaussian measures on Hilbert space — FrnkNlsn · 2026-10-28
- CPR-Dataset: retrievers fail at cross-domain discovery, training gives +70% on BRIGHT — coallaoh · 2026-10-28
- Hugging Face robot duck walks in simulated snow with 290,000 physics-simulated flakes — lukas_m_ziegler · 2026-10-28
- Mercor, Stanford and NBER launch TaskNet, an open-source task catalog updating O*NET for the AI era — soumitrashukla9 · 2026-10-28
- François Fleuret Proposes Tagging Every Token 'Heard/Thought/Said' to Solve Alignment — francoisfleuret · 2026-10-28